Oxidative stress increases delayed neuronal death in the brain following ischemia. As a consequence, many attempts to reduce the damage resulting from cerebral ischemia under more highly oxidized conditions have focused on treatments aimed at maintaining the redox equilibrium of the local environment. This study demonstrates the synergistic effects of combining treatments with alpha-lipoic acid (LA) and vitamin E (VE) as an efficient measure to reduce the damage caused by cerebral ischemia. Two oral therapeutic protocols were examined: intensive treatment (100 mg/kg LA and 140 mg/kg VE for 7 days after ischemia) and prophylactic treatment (20 mg/kg LA and 50 mg/kg VE from 30 days before infarction up to the day of sacrifice). The prophylact...
A persistent reduction in regional cerebral blood flow (CBF) compromises memory and cognitive functi...
Valproic acid (VPA) is an effective drug, which is preferred for the treatments of epilepsy and vari...
Alpha-lipoic acid (aLA) is a strong antioxidant commonly used for treating diabetic polyneuropathy. ...
Oxidative stress increases delayed neuronal death in the brain following ischemia. As a consequence,...
During cerebral ischemia-reperfusion, the enhanced production of oxygen-derived free radicals contri...
Reactive oxygen species (ROS) have been involved in the induction and progression of damage of many ...
Time-dependent changes in antioxidant defence system and the effect ofvitamin C and E supplementatio...
The present study demonstrates the benefits of combinatorial antioxidant therapy in the treatment of...
The present study demonstrates the benefits of combinatorial antioxidant therapy in the treatment of...
Lipoic acid (LA) is a naturally occurring compound and dietary supplement with powerful antioxidant ...
Alpha-lipoic acid (aLA) is a strong antioxidant commonly used for treating diabetic polyneuropathy. ...
BACKGROUND: Neurological injury because of transient cerebral ischemia is a potential complication o...
Background/Aims: Alpha-lipoic acid (α-LA) has been demonstrated to be protective against cerebral is...
Background. Neurological injury because of transient cerebral ischemia is a potential complication o...
Background. Neurological injury because of transient cerebral ischemia is a potential complication o...
A persistent reduction in regional cerebral blood flow (CBF) compromises memory and cognitive functi...
Valproic acid (VPA) is an effective drug, which is preferred for the treatments of epilepsy and vari...
Alpha-lipoic acid (aLA) is a strong antioxidant commonly used for treating diabetic polyneuropathy. ...
Oxidative stress increases delayed neuronal death in the brain following ischemia. As a consequence,...
During cerebral ischemia-reperfusion, the enhanced production of oxygen-derived free radicals contri...
Reactive oxygen species (ROS) have been involved in the induction and progression of damage of many ...
Time-dependent changes in antioxidant defence system and the effect ofvitamin C and E supplementatio...
The present study demonstrates the benefits of combinatorial antioxidant therapy in the treatment of...
The present study demonstrates the benefits of combinatorial antioxidant therapy in the treatment of...
Lipoic acid (LA) is a naturally occurring compound and dietary supplement with powerful antioxidant ...
Alpha-lipoic acid (aLA) is a strong antioxidant commonly used for treating diabetic polyneuropathy. ...
BACKGROUND: Neurological injury because of transient cerebral ischemia is a potential complication o...
Background/Aims: Alpha-lipoic acid (α-LA) has been demonstrated to be protective against cerebral is...
Background. Neurological injury because of transient cerebral ischemia is a potential complication o...
Background. Neurological injury because of transient cerebral ischemia is a potential complication o...
A persistent reduction in regional cerebral blood flow (CBF) compromises memory and cognitive functi...
Valproic acid (VPA) is an effective drug, which is preferred for the treatments of epilepsy and vari...
Alpha-lipoic acid (aLA) is a strong antioxidant commonly used for treating diabetic polyneuropathy. ...